Accordingly, fructose has been indicated to enhance inflammation that promotes cardiac remodeling and cardiac arrhythmias (Figure 1), and it is expected that targeting fructose-induced NF-κB/NLRP3 inflammasome activation and cytokine secretion might reduce cardiac dysfunction. The gene discussed is NLRP3; the disease is cardiac arrhythmia.